TokenPost topic
2 TokenPost stories are tagged Phase 3 trials. The newest appear first.
The six-month, placebo-controlled portion of the trial enrolled 536 men with mild-to-moderate pattern hair loss.
Oct 19, 2026, 10:44 AM EDT · Business
The 183-patient trial tested the drug in two rare blood disorders. Disc Medicine plans to resubmit its FDA application by the end of 2026.
Oct 19, 2026, 8:35 AM EDT · Business